SEC Form 4 · accession 0001354488-16-008580
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy C Barabe
Director
Period of report
Nov 18, 2016
Accepted (ET)
Nov 22, 2016 · 7:31 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 18, 2016 | S | 7,105 | $0.55 | D | 20,719 | D | |
| Common Stock | Nov 18, 2016 | S | 7,809 | $0.5509 | D | 12,910 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (Right to Buy) | $12.00 | Nov 18, 2016 | S | 16,000 | D | Apr 8, 2015 | Apr 8, 2018 | Common Stock | 16,000 | 0 | D |